Infections due to Pseudallescheria/Scedosporium species in patients with advanced HIV disease - a diagnostic and therapeutic challenge

International Journal of Infectious Diseases

Volumn 15, Issue 6, 2011, Pages

  Tammer, Ina ^a   Tintelnot, Kathrin ^b   Braun Dullaeus, Rüdiger C ^a   Mawrin, Christian ^a   Scherlach, Cordula ^a   Schlüter, Dirk ^a   König, Wolfgang ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

AIDS; CNS; HIV; Pseudallescheria; Scedosporium

Indexed keywords

ABACAVIR PLUS LAMIVUDINE; ACICLOVIR; ANTIPARASITIC AGENT; CASPOFUNGIN; CLINDAMYCIN; CORTICOSTEROID; CYTOMEGALOVIRUS ANTIGEN PP65; FLUCONAZOLE; FOLIC ACID; FOSAMPRENAVIR PLUS RITONAVIR; PYRIMETHAMINE; SULFADIAZINE; VORICONAZOLE;

ADULT; AIDS PATIENT; ANISOCORIA; ARTICLE; ATAXIA; BRAIN EMBOLISM; BRAIN INFECTION; CACHEXIA; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; COMA; CONTRAST ENHANCEMENT; CONVULSION; CYTOMEGALOVIRUS INFECTION; DATA BASE; DEATH; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EMPYEMA; EYE MOVEMENT DISORDER; HEMIPLEGIA; HERPES SIMPLEX; HOSPITAL DISCHARGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERREFLEXIA; LUNG DISEASE; MALE; MASTOIDITIS; MICROSCOPY; MORTALITY; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; OROPHARYNX CANDIDIASIS; OSTEOMYELITIS; PARESTHESIA; PETRIELLIDIUM BOYDII; PHARYNGITIS; PNEUMONIA; POLYMERASE CHAIN REACTION; PSEUDALLESCHERIASIS; RESPIRATORY FAILURE; SCEDOSPORIUM; SCEDOSPORIUM APIOSPERMUM; SCEDOSPORIUM PROLIFICAN; SIDE EFFECT; SINUSITIS; SKIN ALLERGY; STUPOR; TASTE DISORDER; TOXOPLASMOSIS; VIRUS LOAD;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; FATAL OUTCOME; FEMALE; HIV INFECTIONS; HUMANS; MYCETOMA; POLYMERASE CHAIN REACTION; PSEUDALLESCHERIA; SCEDOSPORIUM; TOXOPLASMOSIS, CEREBRAL;

EID: 79955975024     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2011.03.004     Document Type: Article

References (69)

1. Kaplan J.E., Benson C., Holmes K.H., Brooks J.T., Pau A., Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009, 58(RR-4):1-207.
2. Antinori S., Nebuloni M., Magni C., Fasan M., Adorni F., Finazzi M.G., et al. Trends in the postmortem diagnosis of opportunistic invasive fungal infections in patients with AIDS: a retrospective study of 1,630 autopsies performed between 1984 and 2002. Am J Clin Pathol 2009, 132:221-227.
3. De Pauw B., Walsh T.J., Donnelly J.P., Stevens D.A., Edwards J.E., Calandra T., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821.
4. Gilgado F., Cano J., Gene J., Guarro J. Molecular phylogeny of the Pseudallescheria boydii species complex: proposal of two new species. J Clin Microbiol 2005, 43:4930-4942.
5. Gilgado F., Cano J., Gene J., Sutton D.A., Guarro J. Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii. J Clin Microbiol 2008, 46:766-771.
6. Raffanti S.P., Fyfe B., Carreiro S., Sharp S.E., Hyma B.A., Ratzan K.R. Native valve endocarditis due to Pseudallescheria boydii in a patient with AIDS: case report and review. Rev Infect Dis 1990, 12:993-996.
7. Scherr G.R., Evans S.G., Kiyabu M.T., Klatt E.C. Pseudallescheria boydii infection in the acquired immunodeficiency syndrome. Arch Pathol Lab Med 1992, 116:535-536.
8. Wood G.M., McCormack J.G., Muir D.B., Ellis D.H., Ridley M.F., Pritchard R., et al. Clinical features of human infection with Scedosporium inflatum. Clin Infect Dis 1992, 14:1027-1033.
9. Garland J, Stool E, Gathe J, Micheletti G, Oliphant J, Renaldi M. Disseminated Scedosporium inflatum infection in a patient with AIDS. Int Conf AIDS 1992; 8:81.(abstract No. PuB 7196).
10. Meyer R.D., Gaultier C.R., Yamashita J.T., Babapour R., Pitchon H.E., Wolfe P.R. Fungal sinusitis in patients with AIDS: report of 4 cases and review of the literature. Medicine (Baltimore) 1994, 73:69-78.
11. Hopwood V., Evans E.G., Matthews J., Denning D.W. Scedosporium prolificans, a multi-resistant fungus from a UK AIDS patient. J Infect 1995, 30:153-155.
12. Nenoff P., Gutz U., Tintelnot K., Bosse-Henck A., Mierzwa M., Hofmann J., et al. Disseminated mycosis due to Scedosporium prolificans in an AIDS patient with Burkitt lymphoma. Mycoses 1996, 39:461-465.
13. Busaba N.Y., Poulin M. Invasive Pseudallescheria boydii fungal infection of the temporal bone. Otolaryngol Head Neck Surg 1997, 117:S91-S94.
14. Montero A., Cohen J.E., Fernandez M.A., Mazzolini G., Gomez C.R., Perugini J. Cerebral pseudallescheriasis due to Pseudallescheria boydii as the first manifestation of AIDS. Clin Infect Dis 1998, 26:1476-1477.
15. Gonzalez Praetorius A., del Palacio A., Perez Pomata M.T., Diaz M., Perez S., Alen M.J., et al. Fungemia caused by Scedosporium prolificans (inflatum) in a patient with AIDS. Enferm Infecc Microbiol Clin 1998, 16:382-383.
16. Horton C.K., Huang L., Gooze L. Pseudallescheria boydii infection in AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1999, 20:209-211.
17. Eckburg P.B., Zolopa A.R., Montoya J.G. Invasive fungal sinusitis due to Scedosporium apiospermum in a patient with AIDS. Clin Infect Dis 1999, 29:212-213.
18. Slack C.L., Watson D.W., Abzug M.J., Shaw C., Chan K.H. Fungal mastoiditis in immunocompromised children. Arch Otolaryngol Head Neck Surg 1999, 125:73-75.
19. Rollot F., Blanche P., Richaud-Thiriez B., Le Pimbec-Barthes F., Riquet M., Dusser D., et al. Pneumonia due to Scedosporium apiospermum in a patient with HIV infection. Scand J Infect Dis 2000, 32:439.
20. Yao M., Messner A.H. Fungal malignant otitis externa due to Scedosporium apiospermum. Ann Otol Rhinol Laryngol 2001, 110:377-380.
21. Idigoras P., Perez-Trallero E., Pineiro L., Laruskain J., Lopez-Lopategui M.C., Rodriguez N., et al. Disseminated infection and colonization by Scedosporium prolificans: a review of 18 cases, 1990-1999. Clin Infect Dis 2001, 32:E158-E165.
22. Del Palacio A., Garau M., Amor E., Martinez-Alonso I., Calvo T., Carrillo-Munoz A., et al. Case reports. Transient colonization with Scedosporium prolificans. Report of four cases in Madrid. Mycoses 2001, 44:321-325.
23. Zaas D. Cases from the Osler Medical Service at Johns Hopkins University. Scedosporium apiospermum mycetoma of the lung. Am J Med 2002, 113:760-762.
24. Garcia J., Perkins A., Garau M., Gene J., Molina L., del Palacio A. Successful treatment with voriconazole of a Pseudallescheria boydii fungus ball in a HIV positive patient and previous tuberculosis. Rev Iberoam Micol 2003, 20:64-67.
25. Abzug M.J., Walsh T.J. Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children. Pediatr Infect Dis J 2004, 23:769-773.
26. Mazumder S.A., Cleveland K.O., Norwood J. Scedosporium apiospermum infection presenting as a pneumothorax and cavitary lung lesions in a patient with acquired immune deficiency syndrome. South Med J 2010, 103:960-962.
27. Sarva S.T., Manjunath S.K., Baldwin H.S., Robins D.B., Freire A.X. Lung scedosporiosis in human immunodeficiency virus/acquired immunodeficiency syndrome. Am J Med Sci 2010, 339:300-303.
28. Husain S., Munoz P., Forrest G., Alexander B.D., Somani J., Brennan K., et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis 2005, 40:89-99.
29. Jabado N., Casanova J.L., Haddad E., Dulieu F., Fournet J.C., Dupont B., et al. Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease. Clin Infect Dis 1998, 27:1437-1441.
30. Revankar S.G., Patterson J.E., Sutton D.A., Pullen R., Rinaldi M.G. Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis 2002, 34:467-476.
31. Ruchel R., Wilichowski E. Cerebral Pseudallescheria mycosis after near-drowning. Mycoses 1995, 38:473-475.
32. Tammer I., Seibold M., Krause H., Tintelnot K., Konig W., Konig B. Successful topical therapy with voriconazole: pseudallescheriasis after injury. J Trauma 2007, 62:1295-1297.
33. Wallace J.M., Lim R., Browdy B.L., Hopewell P.C., Glassroth J., Rosen M.J., et al. Risk factors and outcomes associated with identification of Aspergillus in respiratory specimens from persons with HIV disease. Pulmonary Complications of HIV Infection Study Group. Chest 1998, 114:131-137.
34. Cortez K.J., Roilides E., Quiroz-Telles F., Rinaldi M.G., Shea Y.R., Knudsen T., et al. Infections caused by Scedosporium spp. Clin Microbiol Rev 2008, 21:157-197.
35. Segal B.H., Walsh T.J. Current approaches to diagnosis and treatment of invasive aspergillosis. Am J Respir Crit Care Med 2006, 173:707-717.
36. Ng T.T., Robson G.D., Denning D.W. Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis. Microbiology 1994, 140(Pt 9):2475-2479.
37. Mylonakis E., Barlam T.F., Flanigan T., Rich J.D. Pulmonary aspergillosis and invasive disease in AIDS: review of 342 cases. Chest 1998, 114:251-262.
38. Quinn T.C., Overbaugh J. HIV/AIDS in women: an expanding epidemic. Science 2005, 308:1582-1583.
39. de Hoog G.S., Marvin-Sikkema F.D., Lahpoor G.A., Gottschall J.C., Prins R.A., Gueho E. Ecology and physiology of the emerging opportunistic fungi Pseudallescheria boydii and Scedosporium prolificans. Mycoses 1994, 37:71-78.
40. Slavin M.A. The epidemiology of candidaemia and mould infections in Australia. J Antimicrob Chemother 2002, 49(Suppl 1):3-6.
41. Rabodonirina M., Paulus S., Thevenet F., Loire R., Gueho E., Bastien O., et al. Disseminated Scedosporium prolificans (S. inflatum) infection after single-lung transplantation. Clin Infect Dis 1994, 19:138-142.
42. Feltkamp M.C., Kersten M.J., van der Lelie J., Burggraaf J.D., de Hoog G.S., Kuijper E.J. Fatal Scedosporium prolificans infection in a leukemic patient. Eur J Clin Microbiol Infect Dis 1997, 16:460-464.
43. Panackal A.A., Marr K.A. Scedosporium/Pseudallescheria infections. Semin Respir Crit Care Med 2004, 25:171-181.
44. Segal B.H., Bow E.J., Menichetti F. Fungal infections in nontransplant patients with hematologic malignancies. Infect Dis Clin North Am 2002, 16:935-964. vii.
45. Cimon B., Carrere J., Vinatier J.F., Chazalette J.P., Chabasse D., Bouchara J.P. Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 2000, 19:53-56.
46. Leechawengwongs M., Milindankura S., Liengudom A., Chanakul K., Viranuvatti K., Clongsusuek P. Multiple Scedosporium apiospermum brain abscesses after near-drowning successfully treated with surgery and long-term voriconazole: a case report. Mycoses 2007, 50:512-516.
47. Nesky M.A., McDougal E.C., Peacock J.E. Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis. Clin Infect Dis 2000, 31:673-677.
48. Panichpisal K., Nugent K., Sarria J.C. Central nervous system pseudallescheriasis after near-drowning. Clin Neurol Neurosurg 2006, 108:348-352.
49. Pennekamp P.H., Diedrich O., Zhou H., Kraft C.N. [Foot injury as a rare cause of scedosporiosis with fatal outcome]. Unfallchirurg 2003, 106:865-868.
50. Yoo D., Lee W.H., Kwon-Chung K.J. Brain abscesses due to Pseudallescheria boydii associated with primary non-Hodgkin's lymphoma of the central nervous system: a case report and literature review. Rev Infect Dis 1985, 7:272-277.
51. Tintelnot K., Wagner N., Seibold M., de Hoog G.S., Horre R. Re-identification of clinical isolates of the Pseudallescheria boydii-complex involved in near-drowning. Mycoses 2008, 51(Suppl 3):11-16.
52. Horrè R., Feil E., Stangel A.P., Zhou H., Gilges S., Wohrmann A., et al. [Scedosporiosis of the brain with fatal outcome after traumatization of the foot. Case report]. Mycoses 2000, 43(Suppl 2):33-36.
53. Berenguer J., Rodriguez-Tudela J.L., Richard C., Alvarez M., Sanz M.A., Gaztelurrutia L., et al. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium Prolificans Spanish Study Group. Medicine (Baltimore) 1997, 76:256-265.
54. Kantarcioglu A.S., Guarro J., de Hoog G.S. Central nervous system infections by members of the Pseudallescheria boydii species complex in healthy and immunocompromised hosts: epidemiology, clinical characteristics and outcome. Mycoses 2008, 51:275-290.
55. Kleinschmidt-DeMasters B.K. Central nervous system aspergillosis: a 20-year retrospective series. Hum Pathol 2002, 33:116-124.
56. Satirapoj B., Ruangkanchanasetr P., Treewatchareekorn S., Supasyndh O., Luesutthiviboon L., Supaporn T. Pseudallescheria boydii brain abscess in a renal transplant recipient: first case report in Southeast Asia. Transplant Proc 2008, 40:2425-2427.
57. Castiglioni B., Sutton D.A., Rinaldi M.G., Fung J., Kusne S. Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine (Baltimore) 2002, 81:333-348.
58. Tintelnot K., Just-Nubling G., Horre R., Graf B., Sobottka I., Seibold M., et al. A review of German Scedosporium prolificans cases from 1993 to 2007. Med Mycol 2009, 47:351-358.
59. Rosas A.L., Casadevall A. Melanization decreases the susceptibility of Cryptococcus neoformans to enzymatic degradation. Mycopathologia 2001, 151:53-56.
60. Cuenca-Estrella M., Ruiz-Diez B., Martinez-Suarez J.V., Monzon A., Rodriguez-Tudela J.L. Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum. J Antimicrob Chemother 1999, 43:149-151.
61. Carrillo A.J., Guarro J. In vitro activities of four novel triazoles against Scedosporium spp. Antimicrob Agents Chemother 2001, 45:2151-2153.
62. Troke P., Aguirrebengoa K., Arteaga C., Ellis D., Heath H.C., Lutsar I., et al. Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients. Antimicrob Agents Chemother 2008, 52:1743-1750.
63. Kirkpatrick W.R., Perea S., Coco B.J., Patterson T.F. Efficacy of caspofungin alone and in combination with voriconazole in a guinea pig model of invasive aspergillosis. Antimicrob Agents Chemother 2002, 46:2564-2568.
64. Howden B.P., Slavin M.A., Schwarer A.P., Mijch A.M. Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine. Eur J Clin Microbiol Infect Dis 2003, 22:111-113.
65. Gosbell I.B., Toumasatos V., Yong J., Kuo R.S., Ellis D.H., Perrie R.C. Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery. Mycoses 2003, 46:233-236.
66. Bhat S.V., Paterson D.L., Rinaldi M.G., Veldkamp P.J. Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: successful combination therapy with voriconazole and terbinafine. Scand J Infect Dis 2007, 39:87-90.
67. Katragkou A., Dotis J., Kotsiou M., Tamiolaki M., Roilides E. Scedosporium apiospermum infection after near-drowning. Mycoses 2007, 50:412-421.
68. Whyte M., Irving H., O'Regan P., Nissen M., Siebert D., Labrom R. Disseminated Scedosporium prolificans infection and survival of a child with acute lymphoblastic leukemia. Pediatr Infect Dis J 2005, 24:375-377.
69. Shelburne S.A., Visnegarwala F., Darcourt J., Graviss E.A., Giordano T.P., White A.C., Hamill R.J. Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS 2005, 19:399-409.